Patents by Inventor Soren Peter Olesen

Soren Peter Olesen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potassium channel blocking agents
    Publication number: 20020049246
    Abstract: This invention relates to novel potassium channel blocking agents, and their use in the preparation of pharmaceutical compositions.
    Type: Application
    Filed: December 29, 2000
    Publication date: April 25, 2002
    Applicant: NeuroSearch A/S
    Inventors: Bo Skaaning Jensen, Soren Peter Olesen, Lene Teuber, Dan Peters, Dorte Strobaek
  • Use of isatin derivatives as ion channel activating agents
    Publication number: 20020016354
    Abstract: The present invention relates to ion channel activating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as openers of SKCa and IKCa channels. In further aspects, the present invention relates to the use of these SK/IK channel activating agents for the manufacture of medicaments and pharmaceutical compositions comprising the SK/IK channel activating agents.
    Type: Application
    Filed: May 15, 2001
    Publication date: February 7, 2002
    Inventors: Bo Skaaning Jensen, Tino Dyhring Jorgensen, Philip K. Ahring, Palle Christophersen, Dorte Strobaek, Lene Teuber, Soren Peter Olesen
  • Bis (benzimidazole) derivatives serving as potassium blocking agents
    Patent number: 6194447
    Abstract: This invention relates to novel potassium channel blocking agents, and their use in the preparation of pharmaceutical compositions.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: February 27, 2001
    Assignee: Neurosearch A/S
    Inventors: Bo Skaaning Jensen, Søren Peter Olesen, Lene Teuber, Dan Peters, Dorte Strøbæk
  • Benzimidazole derivatives, their preparation and pharmaceutical use
    Patent number: 5475015
    Abstract: A compound having the formula ##STR1## wherein X is O, SR.sup.4, R.sup.5, R.sup.6 and R.sup.7 independently of each other are hydrogen, halogen, or CF.sub.3 ;R' is hydrogen or NO.sub.2 ; andfurther a method of treating a disorder or disease of a living animal body, including a human, which is responsive to opening of potassium channels, which comprises administering to a living animal body, including a human, in need thereof an effective amount of a compound as above.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: December 12, 1995
    Assignee: NeuroSearch A/S
    Inventors: Soren-Peter Olesen, Leif H. Jensen, Peter Moldt
  • Benzimidazole derivatives, their preparation and use
    Patent number: 5200422
    Abstract: A compound having the formula ##STR1## wherein R.sup.1 is hydrogen, NH.sub.2 or C.sub.1-6 -alkyl which may be branched;X is O, S, NCN;Y is O, S;R.sup.4, R.sup.5, R.sup.6 and R.sup.7 independently of each other are hydrogen, halogen, CF.sub.3, NO.sub.2, NH.sub.2, OH, C.sub.1-6 -alkoxy, C(.dbd.O)-phenyl or SO.sub.2 NR.sup.I R.sup.II wherein R.sup.I and R.sup.II independently are hydrogen or C.sub.1-6 -alkyl;R.sup.11 is hydrogen, halogen, NO.sub.2 or SO.sub.2 NR'R" wherein R' and R" independently are hydrogen or C.sub.1-6 -alkyl;R.sup.13 is hydrogen, halogen, phenyl, CF.sub.3, NO.sub.2 ;R.sup.12 is hydrogen or together with R.sup.13 forms a C.sub.4-7 -carbocyclic ring which may be aromatic or partially saturated;R.sup.14 is hydrogen or together with R.sup.13 forms a C.sub.
    Type: Grant
    Filed: July 17, 1991
    Date of Patent: April 6, 1993
    Assignee: NeuroSearch A/S
    Inventors: Soren-Peter Olesen, Frank Watjen
  • Indole derivatives as potassium channel blockers
    Patent number: 5158969
    Abstract: A method of treating a disease in a mammal, including a human, responsive to blockade of potassium channels, which comprises administering to a mammal in need thereof an effective amount of a compound having the formula ##STR1## wherein R.sup.11, R.sup.12, R.sup.13, R.sup.14 and R.sup.15 independently of each other are hydrogen, CF.sub.3, NO.sub.2, NH.sub.2, OH, C.sub.1-6 -alkyl, C.sub.1-6 -alkoxy or phenyl; andR.sup.4, R.sup.5, R.sup.6 and R.sup.7 independently of each other are hydrogen, halogen, CF.sub.3, C.sub.1-6 -alkyl, NO.sub.2, NH.sub.2, OH or C.sub.1-6 -alkoxy,and a method as above wherein 1-(4-methoxyphenyl)-indole is employed,and a method as above wherein depression, memory disorders, Alzheimers disease and diabetes 2 is treated,and further a method as above wherein the active ingredient is administered in the form of a pharmaceutical composition thereof, in which it is present together with a pharmaceutically-acceptable carrier or diluent.
    Type: Grant
    Filed: August 21, 1991
    Date of Patent: October 27, 1992
    Assignee: NeuroSearch A/S
    Inventors: Soren-Peter Olesen, Leif H. Jensen, Peter Moldt, Mikkel Thaning